Tuesday, 1 March 2022

00:00

Jan LötvallKeynote Presentation

Title to be Confirmed.
Jan Lötvall, Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles, Sweden

00:00

Bernd GiebelKeynote Presentation

Title to be Confirmed.
Bernd Giebel, Group Leader, University Hospital Duisburg-Essen, Germany

00:00

Chulhee ChoiKeynote Presentation

Title to be Confirmed.
Chulhee Choi, Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated, Korea South

00:00

Title to be Confirmed.
Bas WM van Balkom, Assistant Professor, University Medical Center Utrecht, Netherlands

00:00

Title to be Confirmed.
Roel Schaapveld, Chief Executive Officer, InteRNA Technologies BV, Netherlands

00:00

Title to be Confirmed.
Michael Pfaffl, Professor, Technical University of Munich, Germany

00:00

Alain BrissonKeynote Presentation

Title to be Confirmed.
Alain Brisson, Professor Emeritus, University of Bordeaux, France

00:00

Title to be Confirmed.
Erik Vollebregt, Partner, Axon Lawyers, Netherlands

00:00

Title to be Confirmed.
Michiel Pegtel, Associate Professor, Cancer Center Amsterdam, VU University Medical Center, Netherlands

00:00

Sai Kiang LimKeynote Presentation

Title to be Confirmed.
Sai Kiang Lim, Research Director, Institute of Medical Biology, A*STAR, Singapore

00:00

BloodPAC: Establishing Standards and Aggregating Data to Accelerate Development, Approval and Accessibility of Liquid Biopsy Technology
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC), United States of America

The Blood Profiling Atlas in Cancer (BloodPAC) looks to improve outcomes for patients with cancer. To address this challenge, BloodPAC established a collaborative infrastructure to develop standards and best practices, organize and coordinate research studies through its members and operate the BloodPAC Data Commons (BPDC) to support the exchange of raw and processed data generated by the liquid biopsy research community. Data from retrospective basic, clinical and regulatory member studies, as well as projects BloodPAC has prospectively organized since its inception, is aggregated and contributed to the BPDC to establish an open, publicly accessible data commons for the global liquid biopsy community. Today, the BloodPAC is entirely member funded and member driven. In addition to developing standards and aggregating data, BloodPAC works collaboratively with all stakeholders in the field to broaden awareness and implementation of the suggested guidelines and establish a wider chain of feedback and discussion in the community. BloodPAC’s unique approach to collaboration in the field has led to the organization’s success and helps to guide our work into the future.

00:00

Lorena DiéguezKeynote Presentation

Title to be Confirmed
Lorena Diéguez, Leader of the Medical Devices Research Group, INL- International Iberian Nanotechnology Laboratory, Portugal

00:00

Steve SoperKeynote Presentation

Title to be Confirmed.
Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology, United States of America

00:00

Danilo TagleKeynote Presentation

Title to be Confirmed.
Danilo Tagle, Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS), United States of America

00:00

Jennifer JonesKeynote Presentation

Title to be Confirmed.
Jennifer Jones, NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, United States of America